4//SEC Filing
FOLETTA MARK G 4
Accession 0001093557-25-000228
CIK 0001093557other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 4:08 PM ET
Size
7.9 KB
Accession
0001093557-25-000228
Insider Transaction Report
Form 4
DEXCOM INCDXCM
FOLETTA MARK G
Director
Transactions
- Sale
Common Stock
2025-07-15$85.17/sh−2,742$233,528→ 53,879 total(indirect: By Trust) - Sale
Common Stock
2025-07-15$86.03/sh−8$688→ 53,871 total(indirect: By Trust)
Holdings
- 5,731
Common Stock
Footnotes (4)
- [F1]On March 13, 2025, The Foletta Family Trust DTD 1/30/2015 (the "Trust") adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by the Trust. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- [F2]This transaction was executed in multiple trades at prices ranging from $84.815 to $85.44. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- [F3]Shares are held by The Foletta Family Trust DTD 1/30/2015, with respect to which the reporting person is a trustee.
- [F4]Represents unvested restricted stock units which were granted on May 8, 2025 and shall vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2026 Annual Meeting of Stockholders.
Documents
Issuer
DEXCOM INC
CIK 0001093557
Entity typeother
Related Parties
1- filerCIK 0001236389
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 4:08 PM ET
- Size
- 7.9 KB